Cargando…

The Law and Ethics of Switching from Biologic to Biosimilar in Canada

Governments and financial institutions in several jurisdictions are planning or implementing nonmedical/‘forced’ switches by cutting drug coverage for reference biologics and funding only less expensive biosimilars. Switches raise numerous ethical and legal challenges, as the drugs are framed as not...

Descripción completa

Detalles Bibliográficos
Autores principales: Murdoch, Blake, Caulfield, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465550/
https://www.ncbi.nlm.nih.gov/pubmed/32905067
http://dx.doi.org/10.1093/jcag/gwz043